These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6230195)

  • 1. Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers.
    Naranjo CA; Sellers EM; Roach CA; Woodley DV; Sanchez-Craig M; Sykora K
    Clin Pharmacol Ther; 1984 Mar; 35(3):374-81. PubMed ID: 6230195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers.
    Sellers EM; Naranjo CA; Kadlec K
    J Clin Psychopharmacol; 1987 Dec; 7(6):417-20. PubMed ID: 2963034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serotonin uptake inhibitor citalopram attenuates ethanol intake.
    Naranjo CA; Sellers EM; Sullivan JT; Woodley DV; Kadlec K; Sykora K
    Clin Pharmacol Ther; 1987 Mar; 41(3):266-74. PubMed ID: 3469057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the effects of zimelidine on the pharmacokinetics and pharmacodynamics of temazepam in healthy volunteers.
    Fagan D; Scott DB; Tiplady B
    Psychopharmacology (Berl); 1984; 82(3):252-5. PubMed ID: 6144128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of ethanol intake by serotonin uptake inhibitors.
    Naranjo CA; Sellers EM; Lawrin MO
    J Clin Psychiatry; 1986 Apr; 47 Suppl():16-22. PubMed ID: 3007443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of citalopram on alcohol intake in heavy drinkers.
    Balldin J; Berggren U; Engel J; Eriksson M; Hård E; Söderpalm B
    Alcohol Clin Exp Res; 1994 Oct; 18(5):1133-6. PubMed ID: 7847595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of possible interactions between zimelidine, a serotonin uptake inhibitor, and ethanol ingested conjointly in human subjects.
    Brown ZW; Amit Z; Sutherland A; Rockman G; Selvaggi N; Ogren SO
    Neurosci Lett; 1981 Dec; 27(3):351-5. PubMed ID: 6460207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake.
    Balldin J; Berggren U; Bokström K; Eriksson M; Gottfries CG; Karlsson I; Wålinder J
    Drug Alcohol Depend; 1994 Jun; 35(3):245-8. PubMed ID: 7956755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers.
    Naranjo CA; Sellers EM
    Recent Dev Alcohol; 1989; 7():255-66. PubMed ID: 2522667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of prenatal exposure to ethanol on adult ethanol preference and response to zimelidine in rats.
    Grace GM; Rockman GE; Glavin GB
    Alcohol Alcohol; 1986; 21(1):25-31. PubMed ID: 2937414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine.
    Saletu B; Grünberger J; Linzmayer L
    J Neural Transm; 1986; 67(3-4):241-66. PubMed ID: 2949057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain.
    Gourlay GK; Cherry DA; Cousins MJ; Love BL; Graham JR; McLachlan MO
    Pain; 1986 Apr; 25(1):35-52. PubMed ID: 2940499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.
    Naranjo CA; Poulos CX; Bremner KE; Lanctôt KL
    Clin Pharmacol Ther; 1992 Jun; 51(6):729-39. PubMed ID: 1535302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance among heavy alcohol users in clinical drug trials.
    Sullivan JT; Naranjo CA; Sellers EM
    J Subst Abuse; 1988-1989; 1(2):183-94. PubMed ID: 2980999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients.
    Shipley JE; Kupfer DJ; Dealy RS; Griffin SJ; Coble PA; McEachran AB; Grochocinski VJ
    Clin Pharmacol Ther; 1984 Aug; 36(2):251-9. PubMed ID: 6235082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of serotonin in zimelidine-induced hyperglycemia in mice.
    Sugimoto Y; Inoue K; Yamada J
    Biol Pharm Bull; 1999 Nov; 22(11):1240-1. PubMed ID: 10598036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of viqualine on alcohol intake and other consummatory behaviors.
    Naranjo CA; Sullivan JT; Kadlec KE; Woodley-Remus DV; Kennedy G; Sellers EM
    Clin Pharmacol Ther; 1989 Sep; 46(3):301-9. PubMed ID: 2673621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saliva secretion rate and saliva composition as a model to determine the effect of antidepressant drugs on cholinergic and noradrenergic transmission.
    von Knorring L; Mörnstad H
    Neuropsychobiology; 1986; 15(3-4):146-54. PubMed ID: 2431344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zimelidine does not antagonise the effects of alcohol or diazepam on the acquisition of conditioned fear in mice.
    Sanger DJ; Joly D
    Neuropsychobiology; 1986; 15(1):29-33. PubMed ID: 2941693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.